Klin Onkol 1995; 8(Zvláštní číslo): 10-12.
Abstract: The role of primary retroperitoneal lymph-node dissection in clinical stage I, IIA/IIB, resp. chemotherapy is discussed. The author critically evaluates surveillance policy in clinical stage I on the basis of his own experiences. Surveillance policy is recommended only in patients with favourable prognostic factors (without vascular invasion in the primary tumour). A more active therapeutic approach is recommended in other patients.
